Novo Nordisk reported 17.47 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
Bausch Health Companies 11.37 2.38 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
Eli Lilly 37 7.55 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
Merck 8.58 4.74 Jun/2025
Novartis 15.89 3.03 Jun/2025
Novo Nordisk 17.47 3.29 Jun/2025
Novo Nordisk 21.15 18.44 Mar/2025
Pacira 23.09 5.46 Jun/2025
Sanofi 16.47 6.85 Jun/2025
Supernus Pharmaceuticals 22.02 2.92 Jun/2025